{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:39:48Z","timestamp":1782823188710,"version":"3.54.5"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.ejpb.2011.06.009","type":"journal-article","created":{"date-parts":[[2011,7,6]],"date-time":"2011-07-06T13:57:47Z","timestamp":1309960667000},"page":"508-518","source":"Crossref","is-referenced-by-count":16,"title":["Preparation and evaluation of a freeze-dried oral killed cholera vaccine formulation"],"prefix":"10.1016","volume":"79","author":[{"given":"Annika","family":"Borde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Holmgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Nygren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2011.06.009_b0005","unstructured":"WHO, Cholera, 2009, Weekly Epidemiological Report, 85, 2010, pp. 293\u2013308."},{"key":"10.1016\/j.ejpb.2011.06.009_b0010","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1473-3099(07)70138-X","article-title":"The true burden and risk of cholera: implications for prevention and control","volume":"7","author":"Zuckerman","year":"2007","journal-title":"The Lancet Infectious Diseases"},{"key":"10.1016\/j.ejpb.2011.06.009_b0015","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1128\/CDLI.2.6.685-688.1995","article-title":"Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1","volume":"2","author":"Qadri","year":"1995","journal-title":"Clinical and Diagnostic Laboratory Immunology"},{"key":"10.1016\/j.ejpb.2011.06.009_b0020","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.tibs.2003.10.002","article-title":"The intracellular voyage of cholera toxin: going retro","volume":"28","author":"Lencer","year":"2003","journal-title":"Trends in Biochemical Sciences"},{"key":"10.1016\/j.ejpb.2011.06.009_b0025","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s00018-008-7496-5","article-title":"Cholera toxin structure, gene regulation and pathophysiological and immunological aspects","volume":"65","author":"S\u00e1nchez","year":"2008","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.1016\/j.ejpb.2011.06.009_b0030","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.biocel.2007.07.005","article-title":"Vibrio cholerae: cholera toxin","volume":"39","author":"Vanden Broeck","year":"2007","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"10.1016\/j.ejpb.2011.06.009_b0035","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/infdis\/158.1.60","article-title":"Field trial of oral cholera vaccines in Bangladesh: results of one year of follow-up","volume":"158","author":"Clemens","year":"1988","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.ejpb.2011.06.009_b0040","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/infdis\/158.2.372","article-title":"Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial","volume":"158","author":"Clemens","year":"1988","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.ejpb.2011.06.009_b0045","series-title":"New Generation Vaccines","article-title":"Oral cholera vaccines","author":"Holmgren","year":"2009"},{"key":"10.1016\/j.ejpb.2011.06.009_b0050","series-title":"Encyclopedia of Pharmaceutical Technology","first-page":"1807","article-title":"Freeze drying","author":"Pikal","year":"2006"},{"key":"10.1016\/j.ejpb.2011.06.009_b0055","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0304-4157(88)90015-9","article-title":"Interactions of sugars with membranes","volume":"947","author":"Crowe","year":"1988","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.ejpb.2011.06.009_b0060","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1128\/AEM.61.10.3592-3597.1995","article-title":"Trehalose and sucrose protect both membranes and proteins in intact bacteria during drying","volume":"61","author":"Leslie","year":"1995","journal-title":"Applied and Environmental Microbiology"},{"key":"10.1016\/j.ejpb.2011.06.009_b0065","article-title":"Bacterial lipopolysaccharide extraction with phenol:water and further application of the procedure","volume":"5","author":"Westphal","year":"1965","journal-title":"Methods in Carbohydrate Chemistry"},{"key":"10.1016\/j.ejpb.2011.06.009_b0070","doi-asserted-by":"crossref","first-page":"6784","DOI":"10.1016\/j.vaccine.2008.10.011","article-title":"Murine antibody responses following systemic or mucosal immunization with viable or inactivated Vibrio cholerae","volume":"26","author":"Nygren","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2011.06.009_b0075","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/JCM.17.4.596-600.1983","article-title":"Rapid GM1-enzyme-linked immunosorbent assay with visual reading for identification of Escherichia coli heat-labile enterotoxin","volume":"17","author":"Svennerholm","year":"1983","journal-title":"Journal of Clinical Microbiology"},{"key":"10.1016\/j.ejpb.2011.06.009_b0080","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1128\/IAI.01197-08","article-title":"Establishment of an adult mouse model for direct evaluation of the efficacy of vaccines against Vibrio cholerae","volume":"77","author":"Nygren","year":"2009","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.ejpb.2011.06.009_b0085","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1128\/IAI.66.2.514-520.1998","article-title":"Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates","volume":"66","author":"Johansson","year":"1998","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.ejpb.2011.06.009_b0090","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1128\/IAI.71.1.287-297.2003","article-title":"Impact of vector priming on the immunogenicity of recombinant salmonella vaccines","volume":"71","author":"Vindurampulle","year":"2003","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.ejpb.2011.06.009_b0095","series-title":"Encyclopedia of Pharmaceutical Technology","first-page":"2567","article-title":"Particle engineering","author":"Franchini","year":"2006"},{"key":"10.1016\/j.ejpb.2011.06.009_b0100","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0168-3659(90)90133-E","article-title":"Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer\u2019s patches","volume":"11","author":"Eldridge","year":"1990","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/j.ejpb.2011.06.009_b0105","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/infdis\/163.6.1235","article-title":"Field trial of oral cholera vaccines in Bangladesh: serum vibriocidal and antitoxic antibodies as markers of the risk of cholera","volume":"163","author":"Clemens","year":"1991","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.ejpb.2011.06.009_b0110","series-title":"Vibrio cholerae and Cholera: Molecular to Global Perspectives","first-page":"395","article-title":"Recombinant live cholera vaccines","author":"Levine","year":"1994"},{"key":"10.1016\/j.ejpb.2011.06.009_b0115","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1016\/j.vaccine.2008.05.088","article-title":"Construction of a Vibrio cholerae prototype vaccine strain O395-N1-E1 which accumulates cell-associated cholera toxin B subunit","volume":"26","author":"Rhie","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2011.06.009_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(00)00423-3","article-title":"Lyophilization and development of solid protein pharmaceuticals","volume":"203","author":"Wang","year":"2000","journal-title":"International Journal of Pharmaceutics"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641111001998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641111001998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T05:08:47Z","timestamp":1592716127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641111001998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0939641111001998"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2011.06.009","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}